Jci_page_head_homepage_01 Jci_page_head_homepage_02
Osamu Seguchi, Seiji Takashima, Satoru Yamazaki, Masanori Asakura,, Yoshihiro Asano, Yasunori Shintani, Masakatsu Wakeno, Tetsuo Minamino, Hiroya Kondo, Hidehiko Furukawa, Kenji Nakamaru, Asuka Naito,, Tomoko Takahashi, Toshiaki Ohtsuka, Koichi Kawakami, Tadashi Isomura,, Soichiro Kitamura, Hitonobu Tomoike, Naoki Mochizuki, Masafumi Kitakaze
Published in Volume 117, Issue 10
J Clin Invest. 2007; 117(10):2812–2824 doi:10.1172/JCI30804
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 6
Suppression of z–cardiac-MLCK expression induced dilatation of the cardiac ventricle in zebrafish embryos.

(A and B) Control mock-injected zebrafish embryos and zebrafish embryos injected with z-cMKaugMO produced the phenotype of ventral swelling at 48 hpf (A) and 72 hpf (B). (C) Zebrafish embryos injected with MOs with 5-base mismatch to z-cMKaugMO (z-mismatchMO) showed phenotypes comparable to those of controls. (D and E) Injection of specific MOs designed to interfere with the splicing of z–cardiac-MLCK exon 4 (z-cMKspMO4; D) or exon 6 (z-cMKspMO6; E) or with the splicing of z-MLC2v exon 2 (z-MLCspMO2; F), which coded for the phosphorylatable serine residue, also induced the phenotype of ventral swelling. RT-PCR products amplified from cDNA produced from the morphants were shorter than those obtained from control embryos due to the removal of the targeted exons. (G) Cardiac motion in the control embryos and z-cMKaugMO morphants. Shown are end-diastolic (left) and end-systolic (right) phases of the cardiac ventricular cycle in a control embryo and z-cMKaugMO morphant. (H) Representative M-mode images of both control embryo and z-cMKaugMO morphant hearts. Scale bars: 50 μm. Original magnification, ×20 (AF); ×100 (G).